@kervio was right about full trial enrollment being unlikely by end of December.
This was in the company presentation:
"Full recruitment expected to complete during Q1 CY2021"
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial, page-381
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.44 |
Change
0.000(0.00%) |
Mkt cap ! $1.644B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1110 | $1.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.43 | 1250 | 1 |
View Market Depth
| Last trade - 09.45am 15/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |
Day chart unavailable